Skip to main navigation Skip to search Skip to main content

A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor 06-methylguanine DNA methyltransferase) Glioblastoma

Project: Clinical studiesClinical Study (Industry project)

Project Details

Description

randomisiert, blind
Short titleCA209548
StatusFinished
Effective start/end date16.02.201629.09.2022

Fields of science

  • 302052 Neurology
  • 302058 Palliative medicine
  • 302055 Oncology
  • 302030 Internal medicine